• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: November 2-6, 2009

The FDA Public Calendar contains reports of meetings held by FDA policy makers with persons outside the executive branch of the Federal government.

November 2-6, 2009

 

FDA Official and Title

 

Date

 

Location

 

Other FDA Participants

 

Non-FDA Participants

 

Subject

Margaret A. Hamburg, M.D., Commissioner of Food and Drugs11/2/09Silver Spring, MDVicki Seyfert-Margolis, Leonard Sacks, Jeff O’Neill Jonathan K.C. Knowles, (Hoffman-La Roche)Strengthening cooperative links between the FDA and Critical Path and the Innovative Medicines Initiative
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs11/5/09Silver Spring, MDJesse Goodman, Janet Woodcock, Jeff O’NeillRichard Gephardt, Andie King, (Gephardt Group Government Affairs) Debra Lappin, (Council for American Medical Innovation)Unmet research needs in the arena of regulatory science
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs11/6/09Silver Spring, MDJoshua Sharfstein, Mike Taylor, Jesse Goodman, Bernadette Dunham, William Flynn, Dave White, Steve Vaughn, Joy Dawson, Wanda RussLaura A. Rogers, Robert P. Martin, Shelley Hearne, Shannon Heyck-Williams, (The PEW Charitable Trusts) Lance B. Price, (TGen: The Translational Genomics Research Institute)Nontherapeutic Use of Antimicrobial Drugs in Food-Producing Animals
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs11/6/09Silver Spring, MDJoshua Sharfstein, Karen Midthun, Rick Davey, Josephine TropeaKaren Shoos Lipton, Jackie Fredrick, Theresa WiegmannPatient Safety Regarding the Labeling of Blood Products
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs11/6/09Silver Spring, MDJesse Goodman, Jeff Shuren, Bernadette Dunham, Laura Tarantino, Norris Alderson, Mary Lou Valdez, Robin Alta Charo, Subhas Malghan, Jennifer Ross, Carlos Pena, Nakissa Sadrieh, Linda KatzDavid Rejeski, Andrew Maynard, Eleonore Pauwels, Patrick Polischuk, (Woodrow Wilson International Center for Scholars)Emerging Nanotechnologies
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs11/2/09Silver Spring, MDKaren Weiss, Sandra Kweder, Susan Johnson, Gerald Dal Pan, Carol Holquist, and Jeff O’NeillSeveral representatives from McNeil Consumer HealthcareUse of safety devices on pediatric drug products
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs11/2/09Washington, DCN/ABoard of Directors (Natural Products Assoc.)FDA's interest in health and safety for the American public
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs11/3/09Washington, DCJane Axelrad, Diane Maloney, Jeff Shuren, Michael Chappell, Stephen Sundlof, Tracey Forfa, Luciana Borio, Jeffrey Senger, Afia AsamoahKalah Auchincloss, (Foley Hoag) Tony Corbo, (Food and Water Watch) AnnaMaria DeSalva, (Hill & Knowlton) Barry Dickinson, (AMA) Michael Hinckle, (K&L Gates) Sarah Klein, (CSPI) Diana Zuckerman, (Natl. Research Center for Women & Families) Larry Kohl, (Food Marketing Inst.) Richard Martin, (Am. Soc. for Radiation Oncology)2nd Public Meeting on Transparency
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs11/4/09Silver Spring, MDJanet Woodcock, Bob Rappaport, Wendy Sanhai, Bill Slikker, Doug ThrockmortonRobert Sladen, Margaret Wood, Lena Sun, (Columbia Univ.) Donald Mattison, (NIH) Mary Ellen McCann, (Harvard Medical School) Randall Flick, (Mayo Clinic) Adnan Bhutta, (Arkansas Children's Hospital) Scientific Workshop on the Safety of Key Inhaled and Intravenous Drugs in Pediatrics Initiative
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs11/5/09Baltimore, MDN/AGraduate students and faculty, Johns Hopkins University, School of Public Health2009 Fall Seminar Series
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health11/2/09-11/6/09N/AN/AN/ANo Significant Meetings
Russell Abbott, Acting Deputy Commissioner for Administration and Chief Financial Officer11/2/09- 11/6/09N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs11/1/09Beijing, ChinaN/AN/ALecture at Peking University
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs11/2/09Beijing, China N/AN/APresentation at 1st DIA China Annual Meeting, Drugs in a Flat World:  Innovation, Regulation, and Globalization
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs11/3/09TaipeiN/AN/APresentation at 8th Conference of APEC Network on Pharmaceutical Regulatory Science
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs11/4/09Beijing, ChinaN/AN/APresentation at AQSIQ's China International Food Safety and Quality Conference
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs11/5/09SingaporeN/AN/A2009 Asia Healthcare Forum Roundtable
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget11/2/09-11/6/09N/AN/AN/ANo Significant Meetings 
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research11/6/09Boston, MAN/AOmar Badri, (Director, Tosteson Lecture Series)The Daniel C. Tosteson Health Policy Lecture Series 
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs11/3/09Washington, DCJames StrachanN/ANational Transportation Safety Board (NTSB) Conference Center 
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research11/3/09Bethesda, MDN/AN/AOpening Remarks - DIA Global Vaccine Development for World Heath Symposium - Prequalification of Global Vaccines
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research11/5/09Rockville, MDN/AN/AOpening Remarks - California Institute for Regenerative Medicine - Preclinical Considerations for Stem Cell-Based Products

Robert Yetter, Acting Director*, Center for Biologics Evaluation and Research

 

*officially "Acting" for Karen Midthun

11/4/09Gaithersburg, MDN/AN/AOpening Remarks - Blood Establishment Computer Software
Jeffrey Shuren, M.D., J.D., Acting Director, Center for Devices and Radiological Health11/6/09Silver Spring, MDAlberto Gutierrez, Tim Ulatowski, Steven Pollack, Susan Gardner, Nancy Stade, Courtney Harper, Barbara Zimmerman, Bill MacFarlandTamara Syrek Jensen, Louis Jacques, Lori Paserchias, (Center for Medicare and Medicaid Services CMS) Medical Devices
Stephen Sundlof, D.V.M., P.h.D., Director, Center for Food Safety and Applied Nutrition11/4/09Washington, DCN/AN/ANational Stakeholders Meeting on Reducing Sodium
Bernadette Dunham, D.V.M., P.h.D., Director, Center for Veterinary Medicine11/02/09-11/06/09N/AN/AN/ANo Significant Meetings
William Slikker, Jr., P.h.D., Director, National Center for Toxicological Research11/3/09 - 11/4/09Silver Spring, MDN/AN/ABiannual meeting of the Toxicology Study Selection and Review Committee
William Slikker, Jr., P.h.D., Director, National Center for Toxicological Research11/4/09Silver Spring, MDN/AN/A1st Scientific Workshop of the Safety of Key Inhaled and Intravenous Drugs in Pediatrics (SAFEKIDS) Initiative
William Slikker, Jr., P.h.D., Director, National Center for Toxicological Research11/5/09Stillwater, OKN/AN/APresentation at  the Oklahoma State University
Michael M. Landa, J.D., Acting Chief Counsel11/2/09Rockville, MDNancy Boocker, Elizabeth Dickinson, Donna Katz, Kim Dettelbach, Jeff Senger, Eric Blumberg, Julie TierneyEric Lobenfeld, Philip Katz, David Fox, (Hogan & Hartson) Mike O'Connor, Sean Brennan, John Bellamy, (Graceway Pharmaceuticals)Disclosure Issues
Lawrence Deyton, M.D., M.P.H., Director, Center for Tobacco Products11/6/09Washington, DCGerald McNabbBen Chu, Cheryl Healton, (American Legacy Foundation)Tobacco Control Programs